Indication

Chronic hepatitis C - genotype 3

Chronic hepatitis C - genotype 3 is a persistent viral infection of the liver caused by the genotype 3 strain of the hepatitis C virus, defined clinically by detectable viral RNA persisting for six months or longer. Read more about Chronic hepatitis C - genotype 3

30 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Chronic hepatitis C - genotype 3 therapies.

Showing 28–30 of 30 drugs

Filter & compare in the drug finder →Opens the drug finder with Chronic hepatitis C - genotype 3 preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic hepatitis C - genotype 3.

Chronic hepatitis C - genotype 3 is a persistent viral infection of the liver caused by the genotype 3 strain of the hepatitis C virus, defined clinically by detectable viral RNA persisting for six months or longer.

Primarily affecting hepatic tissue in infected pediatric and adult populations, it exhibits distinct pathophysiologic behavior compared to other viral strains.

Genotype 3 is notably characterized by virus-induced hepatic steatosis, accelerated rates of fibrosis progression, and an increased risk of developing cirrhosis and hepatocellular carcinoma.

While frequently asymptomatic in its early stages, progressive infection can lead to end-stage liver disease, portal hypertension, and hepatic decompensation.

Personalize your experience

Follow Chronic hepatitis C - genotype 3 and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it